Neuroendocrine tumors are a diverse group of cancers that originate in neuroendocrine cells and can affect multiple organs, particularly the gastrointestinal tract, lungs, and pancreas. Advances in diagnostic technologies and treatment approaches are improving disease detection and patient management.
The Neuroendocrine Tumor Treatment Market was valued at US$3.12 billion in 2024 and is...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek